Notably, many splicing factors regulated by the AKT pathway exhibit either oncogenic or tumor-suppressive functions, highlighting the potential of targeting splicing factor pathways as a therapeutic strategy in cancer.135. The gene discussed is AKT1; the disease is neoplasm.